NDC 63083-4021

Low Mycosis Nosode 4021

Low Mycosis Nosode

Low Mycosis Nosode 4021 is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Professional Complementary Health Formulas. The primary component is Aspergillus Niger Var. Niger; Aureobasidium Pullulans Var. Pullutans; Candida Albicans; Candida Torresii; Candida Tropicalis; Geotrichum Candidum; Mucor Racemosus; Penicillin G; Pleospora Herbarum; Rhizopus Stolonifer; Rhodotorula Rubra.

• Product ID: 63083-4021_0f5d64fa-cad8-4ae6-9faa-9886b8c0f622
• NDC: 63083-4021
• Product Type: Human Otc Drug
• Proprietary Name: Low Mycosis Nosode 4021
• Generic Name: Low Mycosis Nosode
• Dosage Form: Liquid
• Route of Administration: ORAL
• Marketing Start Date: 1984-08-15
• Marketing Category: UNAPPROVED HOMEOPATHIC /
• Labeler Name: Professional Complementary Health Formulas
• Substance Name: ASPERGILLUS NIGER VAR. NIGER; AUREOBASIDIUM PULLULANS VAR. PULLUTANS; CANDIDA ALBICANS; CANDIDA TORRESII; CANDIDA TROPICALIS; GEOTRICHUM CANDIDUM; MUCOR RACEMOSUS; PENICILLIN G; PLEOSPORA HERBARUM; RHIZOPUS STOLONIFER; RHODOTORULA RUBRA
• Active Ingredient Strength: 6 [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL
• Pharm Classes: Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Penicillin-class Antibacterial [EPC], Penicillins [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 63083-4021-2

59 mL in 1 BOTTLE, DROPPER (63083-4021-2)

• Marketing Start Date: 1985-08-15
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details